Phibro Animal Health to establish new biotech facility in Sligo, Ireland, creating up to 150 jobs
The project is supported by the Irish Government through IDA Ireland.
Phibro develops, manufactures and markets a broad line of animal health and nutrition products for poultry, swine, cattle, dairy and aquaculture customers around the globe. The company had
The new manufacturing facility will initially focus on producing Phibro’s innovative line of vaccines for the treatment of a range of poultry diseases for sales globally. In the future, Phibro expects to expand production to include vaccines for livestock and aquaculture.
Making the announcement in
Welcoming the announcement, Minister for Business, Enterprise & Innovation,
Speaking at today’s announcement,
Speaking at today’s announcement in
The new roles will include management, quality analysis, quality control, regulatory, engineering, operators and maintenance staff. For more information on the new roles, email firstname.lastname@example.org.
While not immediately material to Phibro’s business, the company believes
Chief Financial Officer
IDA Global Communications, Press Executive
+353 87 667 4712
Source: Phibro Animal Health Corporation